Larson Financial Group LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 203 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
Larson Financial Group LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$39
-13.3%
1000.0%0.00%
Q2 2023$45
-45.1%
1000.0%0.00%
Q1 2023$82
-47.4%
1000.0%0.00%
Q4 2022$1561000.0%0.00%
Q3 2022$01000.0%0.00%
Q2 2022$01000.0%0.00%
Q1 2022$01000.0%0.00%
Q4 2021$0
-100.0%
100
+47.1%
0.00%
-100.0%
Q1 2020$1,000680.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 200,000$998,0000.36%
Green Alpha Advisors, LLC 72,647$363,0000.24%
Skaana Management L.P. 227,851$1,137,0000.18%
SEVEN EIGHT CAPITAL, LP 196,351$980,0000.18%
Skaana Management L.P. 206,300$1,029,0000.16%
Defender Capital, LLC. 103,038$514,0000.16%
WASATCH ADVISORS LP 4,926,125$24,581,0000.10%
Parametrica Management Ltd 16,183$81,0000.08%
Cedar Brook Financial Partners, LLC 54,500$272,0000.07%
Hennion & Walsh Asset Management, Inc. 274,703$1,371,0000.07%
View complete list of INOVIO PHARMACEUTICALS INC shareholders